Informed consent during the clinical emergency of acute myocardial infarction (HER0-2 consent substudy): a prospective observational study
- 1 March 2003
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 361 (9361), 918-922
- https://doi.org/10.1016/s0140-6736(03)12773-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trialThe Lancet, 2001
- Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?Heart, 2001
- Is informed consent to clinical trials an “upside selective” process in acute coronary syndromes?American Heart Journal, 2000
- The impact of disease severity on the informed consent process in clinical researchAmerican Journal Of Medicine, 1996
- Are we promoting true informed consent in cardiovascular clinical trials?Journal of Cardiovascular Nursing, 1995
- Informed consent in European multicentre randomised clinical trials — Are patients really informed?European Journal Of Cancer, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Defining Patient Competence for Medical Decision MakingChest, 1991
- Very early thrombolytic therapy in suspected acute myocardial infarctionThe American Journal of Cardiology, 1990